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Abstract
Gamma-amino butyric acid (GABA) is a major inhibitory neurotransmitter 
found in several regions of the brain and known to have various significant physi-
ological roles as a potent bioactive compound. Malfunction of GABAergic neuronal 
signaling prompts to cause severe psychiatric symptoms in numerous mental disor-
ders. Several drugs are available in clinical practice for neuropsychiatric disorders 
targeting through GABAergic pathway, with notable adverse effects. Interestingly, 
in recent years, researchers are focusing on natural compounds altering GABAergic 
neurotransmission for various psychiatric disorders due to its wide range of thera-
peutic efficacy and safety. The enormous variety of natural compounds, namely 
alkaloids, flavonoids, terpenoids, polyacetylenic alcohols, alkanes and fatty acids 
were reported to alter the GABAergic transmission through its receptors and or by 
influencing the transmission, synthesis and metabolism of GABA. Natural com-
pounds are able to cross the blood brain barrier and influence the GABA functions 
in order to treat anxiety, mania, schizophrenia and cognitive disorders. Therefore, 
this current chapter describes on natural products which have the potential to alter 
the GABAergic neurotransmission and its therapeutical benefits in treating several 
neuropsychiatry disorders using various pharmacological methods.
Keywords: Natural products, GABA, agonist, metabolism, allosteric modulation, 
psychiatric disorders
1. Introduction
The ground breaking discovery of Gamma-aminobutyric acid (GABA) played 
an astonishing role in neural control theory in 1950’s. In the human cortex GABA is 
the primary inhibitory neurotransmitter [1]. In the initial developmental stage of 
life, GABA functions as an excitatory element which influences many physiological 
processes like neuronal proliferation, neurogenesis, migration, differentiation and 
preliminary circuit building. After maturation of CNS, GABA acts as an inhibitory 
neurotransmitter which is controlled as chloride or cation transporter expression. 
GABA also plays a vital role in interstitial neurons development of white matter along 
with oligodendrocyte development. Whereas the basic fundamental cellular mecha-
nisms are not well described though it is proven that a lot of neurological diseases 
are well involved through GABA dependant pathway which includes white matter 
abnormalities, including anoxic-ischemic injury, anxiety, insomnia and schizophrenia 
[2]. GABA receptors are majorly classified into two main types ionotropic GABAA and 
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GABAC receptors and the metabotropic GABAB receptor. GABAA acts by activating 
the fast-hyperpolarizing negative ion channel (Cl−) and diffuse by the means of con-
centration gradient to hyperpolarize post synaptic mature neurons [3, 4]. Whereas 
another kind of ionotropic receptor was discovered GABAC with 3ρ subunits [5]. 
GABAB receptors consist of two subunits, GABAB1and GABAB2 which are responsible 
for slower inhibitory transmission. These receptor activations are coupled with  
K+/Ca+ channels through G-protein mediated secondary pathway [6].
Natural molecules with a wide range of chemical structures have been shown to 
have GABAA receptor modulating potential due to the structural heterogeneity of 
and more than one number of binding sites. It has different pharmacological effects 
depending on the mechanism of action, the binding site and the affinity of the 
compounds. These effects have been investigated using different in vitro and in vivo 
models [7–9].
The versatile binding nature of benzodiazepine binding site of GABA receptor 
allows multiple molecules to bind and modulate the functions of GABA in a very 
specific manner. So, this class of compounds are used for the treatment of anxiety, 
convulsion, insomnia by non-specifically modulating all five α subunits. This non 
selective nature of these compounds generates unwanted side effects like tolerance 
and dependence. Therefore, there is an immediate need for finding safe drugs, with 
increased anxiolytic and decreased sedative potential. In recent decades, various 
reports have been made on natural products with GABAergic activity and, different 
various methods have been used to describe the effects. Hence, this review aimed 
to collect the existing data and make the obtained results as comparable as possible, 
thus facilitating the discussion of structure–activity relationships [10].
1.1 Synthesis
GABA is mainly produced from α-decarboxylation of glutamate by the enzyme 
glutamic acid decarboxylase (GAD) and metabolized by the actions of GABA-
transaminase (GABA-T) and succinic semialdehyde dehydrogenase (SSADH) into 
succinate respectively. Through the use of the pyridoxal-5′-phosphate-dependent 
interconversion steady state concentration of GABA is achieved in-vivo (apo-GAD). 
At least 50 percent of the total GAD present in the brain is apo-GAD [10]. Inorganic 
phosphate promotes the activation of GAD and blocked by aspartate, GABA and 
ATP. The ATP facilitates and stabilizes apo-GAD formation which further stimulates 
the development of GABA. At 37°c temperature apo-GAD has a half-life of few 
minutes without ATP. GAD mainly consists of two isoforms of distinct molecular 
weights (65 and 67 kD) which are the products of chromosomes 2 and 10 in humans.
After synthesis, GABA vesicular release has specific mechanisms. GABA is 
assembled using Mg2
+ activated ATPase into vesicles. This method is energy-depen-
dent and requires adenosine triphosphate and magnesium. Calcium-dependent 
GABA vesicular release appears to result in a temporary increase in the synaptic 
cleft’s GABA concentration and the binding of the receptor to evoke action. 
Through the sodium and chloride reuptake mechanism of the GABA transporter 
(GAT) to the presynaptic neuron and surrounding glia, quick synapse removal 
takes place. GABA is then reused into metabolites that are eventually used for GABA 
resynthesis by breakdown. GABA-oxoglutarate transaminase, succinic semial-
dehyde dehydrogenase and glutamate decarboxylase (GAD) are three enzymes 
required for GABA metabolism and resynthesis. The deterioration of GABA to 
succine semi-aldehyde is catalyzed by the enzyme GABA oxoglutarate transami-
nase. The latter is then oxidized by means of succinic semialdehyde dehydrogenase 
into succinic acid. Ligands associated with these GABA procedures will regulate the 
action of GABA [11].
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2. GABA receptor physiology and GABA ligands
In 1981, GABAA & GABAB subtypes of GABA were discovered by Hill and 
Bowery. GABAA was reported as chlorine sensitive ion channel which is allosteri-
cally modulated by barbiturates, benzodiazepines, neurosteroids and ethanol. 
Along with this GABAB receptors couple with Ca
+ and K+ channels via G protein 
second messenger system. This receptor activation specifically happens through 
baclofen which is resistant through GABAA modulators [12].
As GABAB receptors are dimeric metabotropic in nature and the structure of 
pentameric GABAA receptors ideal for allosteric regulation. So research on these 
receptors is likely to develop novel therapy for the treatment of neurological and 
psychological disorders [13, 14] (Figure 1).
2.1 GABAA receptor
Among the three types of GABA receptors, the GABAA receptor is the best 
characterized one. For several selective ligands, this channel has numerous binding 
sites. One class of therapeutic drugs linked to this target are receptor modulators: 
benzodiazepines, non-benzodiazepines and barbiturates, most of which improve 
the effect of GABA by increasing the chloride channel opening [13].
Figure 1. 
A. The subunits of GABAA receptor and chlorine channel. B. Represents the barbiturate and benzodiazepine 
binding sites on GABA receptor subunits.
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The GABAA agonist, muscimol, antagonist bicuculline and picrotoxin and 
inverse agonist FG 7142 are additional ligands which bind to the GABAA receptor. 
Some of these agents do not seem to have therapeutic benefits, but when used as 
pharmacological tools for the GABAA receptor they are the most significant ligands. 
Neuro-active steroids and partial benzodiazepine agonists (PBAs) are some newly 
discovered agents which are coming into recent considerations [14]. PBAs (e.g., 
bretazenil, imidazenil) are GABAA receptor activators, similar to benzodiazepines. 
Although they tend to have lower effectiveness compared to full benzodiazepine 
agonists, they give a more favorable side effect profile. Compared to other con-
figurations found in more selective areas, this subtype is common throughout the 
brain [15].
2.2 GABAB receptor
GABAB receptors have seven membrane-spanning amino acid domains which 
are connected by a G-protein to its signaling pathway (K+, Ca++ ion channels or 
adenylate cyclase). Presynaptic GABAB receptors are majorly coupled to calcium 
channels and their stimulation by the receptor results in decrease of calcium 
conductance and decline of GABA release. Thus, the receptors auto-regulates the 
discharge of GABAA and gives the GABAA system with negative feedback. On the 
other hand, Post-synaptic GABAB receptors are primarily linked to potassium chan-
nels and their stimulation led to increased conductance of K+, hyperpolarization 
and decreased excitability of the neurons. The opening of T-type calcium channel is 
mainly associated with the actuation of GABAB receptor, resulting in calcium spik-
ing activity that can contribute to absence seizure and is also included in signaling 
through the pathway of adenylate cyclase. It is therefore assumed that mediation of 
the GABAB receptor occurs through at least two distinct subtypes receptor [16–18].
2.3 GABAC receptor
The GABAC receptor, a subtype of GABAA receptor characterization started 
when the analogue of GABA cis-4-aminocrotonic acid (CACA) in cat spinal inter-
neurons developed a depressant action, which was not inhibited by the GABAA 
antagonist bicuculline and varied from the depressant actions of the GABAB agonist 
baclofen. The GABAC receptor is distinguished from both GABAA and GABAB by 
their pharmacological actions. GABAC is structurally different from GABAA because 
GABAC is hetero oligomeric and homo oligomeric which means it composed of 
many subunits of the same subtype, it can be either r1 or r2 [19].
3. GABAergic system and neurological disorders
The main components of brain inhibitory circuits are networks of (GABAergic) 
interneurons in the amygdala [20]. This neurotransmitter is essential to maintain 
a balance between neuronal excitation and inhibition. Both glutamatergic neurons 
and the GABAergic interneurons compose of the basolateral nucleus (BLA). A 
relatively small group of GABAergic inhibitory neurons is closely regulated by 
Glutamatergic neurons. Devastation of GABAergic BLA inhibition, such as anxiety 
and depression, emotional dysregulation, and seizure actions, can cause hyper-
excitability of the The central amygdala (CeA) consisting only of GABAergic 
neurons acts by converging inputs from the BLA as the primary output nucleus 
of the amygdala. In addition, the BLA, the central amygdala and all their associa-
tions play a key role in the regulation of the GABAergic system. As a result, these 
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GABAergic amygdala neurons are properly trained to perform a central role in the 
stress management. Nonetheless, even less is known about the association between 
the GABAergic amygdala inhibitory system and stress [21].
The sedative and hypnotic effects are mediated by α1 subunit of GABAA recep-
tors, whereas the anxiolytic effect is exhibited by the positive regulation of α2 and 
(or) α3 subunit of GABAA receptors. Furthermore, in learning and memory, the α5 
subunits play an important role. The cause of side effects, such as muscle relaxation 
or anterograde amnesia, is because of benzodiazepines, which are widely used in 
the treatment of anxiety, insomnia and seizures, functioning on various subunits 
(α1, α2, α3 and α5). Such drawbacks include the growth of resistance and depen-
dence. The development of new and safer drugs with, for example, an efficient 
anxiolytic yet low sedative potential is therefore urgently warranted. Various 
studies have recently been performed on natural products with GABAergic involve-
ment, and various types of approaches have been used to clarify the findings. 
Consequently, the purpose of this analysis is to gather current evidence and gener-
ate the findings obtained, thereby promoting the discussion of structure activity 
relationships [9].
In knock-out mice special kind of GABAB receptors are being introduced in mice 
that lack subunits of the GABAB receptor. In addition to psychiatric conditions, the 
phenotype of these mice shows evidence of GABAB receptor activation in epilepsy, 
sensorimotor gating, nociception and temperature control [22]. With almost the 
same behavioral phenotype as GABAB1 Knockout mice whereas mice that lack the 
GABAB2 subunit are currently developed. Some data suggest that these phenotypes 
underlie the lack of heteromeric GABAB1 and GABAB2 receptors. In order to evaluate 
the anxiolytic ability of other positive GABAB receptor modulators, further stud-
ies are required, but current evidence suggests that they may be a new category of 
anxiolytics with a higher side effect profile than benzodiazepines. The mechanisms 
involved in the anxiety activity impact of GABAB receptors are not well known. 
Future research should also focus on behavioral and electrophysiological approaches 
to the activation of GABAB receptors in major anxiety-related brain regions [23].
3.1 GABAergic system in schizophrenia
In late adolescence or early adulthood, schizophrenia is a mental health condi-
tion that commonly occurs. Its impact on speech, thinking, emotions and other 
areas of life can affect the social interactions and daily activities of people. In the 
presynaptic neuron, the carrier protein is available in GAT-1 and is mainly respon-
sible for GABA reuptake in synapse. It plays a significant role in both phasic and 
tonic inhibition which is regulated by GABA. The synaptic potential of GABA is 
terminated by GAT-1 and it is managed by the duration and adequacy of GABAergic 
neurotransmission therefore, decreased GAT-1 levels demonstrate enhanced 
accessibility of GABA. In schizophrenia, numerous studies show decreased levels 
of mRNA encoding for the GAT-1 protein along with the decreased expression of 
GAD 67 mRNA. GAT-1 mRNA delivery is decreased and generally unchanged in 
most GABAergic neurons. GAT-1 mRNA concentration fluctuations are recognized 
in chandelier neurons. In schizophrenia, the thickness of immunoreactive GAT-1 
cartridges is reduced, although axon terminal marker in other populations remains 
unaltered. Relatively low GAT-1 immunoreactive cartridge thickness indicates 
a significantly reduced GAT-1 protein correlated with a reduced level of GAT-1 
mRNA. Therefore, in individuals with schizophrenia, the amount of GAT-1 protein-
enclosing chandelier neurons decreased whereas the number of neurons comprising 
parvalbumin remained consistent. This outcome infers that the decreased degrees 
of GAT-1 mRNA are restricted to chandelier neurons.
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The decline of GAD67 mRNA coding in the prefrontal dorsolateral cortex is the 
most predictable post-mortem finding in schizophrenia, which led to decrease in 
GAD67 levels of protein, despite the fact that this has been less widely considered. 
The schizophrenia-influenced subset tends to incorporate GABAergic neurons 
comprising parvalbumin. Expression of parvalbumin mRNA in schizophrenia is 
diminished in layer 3 and 4 of the prefrontal cortex (PFC). In the prefrontal cortex 
(PFC), the recent discovery indicates that the decreased articulation of GAD67 
mRNA is unique for the GABA neuron subgroup [24].
Adequate histopathological data also suggests that, the association of GABAergic 
neurotransmission impairment with pathologies and cognitive dysfunctions of 
schizophrenia. The primary motor cortex (PMC), primary visual cortex (VC), 
anterior cingulate cortex (ACC) is distinguished by the similar GABAergic gene 
expression deficits as shown in the Dorsolateral prefrontal cortex, which includes 
selective parvalbumin-containing GABA neuron involvement. The greatest 
decreases in mRNA encoding levels for parvalbumin have been reported. In serious 
case reduction in the α1 and δ subunits of GABA receptors, GAD67 mRNA, GAD65 
mRNA and GAT-1 mRNA is displayed in the brain regions [10, 25].
3.2 GABAergic system in anxiety and depression
Both in animals and humans, depression and anxiety are most frequent causes 
of persistent stress. Two mechanisms are defined by anxiety models: fear processes 
are believed to be developed to allow us to change our emphasis on the first hint of 
risk and behavioral modification in order to prevent or eliminate an imminent or 
predicted overt danger [26].
The long-term potential activity strongly depends on the augmentation of 
GABA signaling which process through the GABAA receptors namely α1 and α2. 
The long-term potential response triggers are not only restricted to GABAA but 
also to the GABAB receptor. The GABAB receptor antagonists causing the long-term 
potential response on cortical along with thalamic centripetal synapses whereas 
the thalamic feed needs postsynaptic response from NMDA-receptor. The cortical 
actions controlled by pre-synaptic response on increased glutamate response by 
NMDA receptor independent activity, so activating GABA synapse thereby induc-
ing GABAB receptor might help to arrest non associated long-term potential there 
by reducing agitation response [27].
By protruding to the central amygdala (CEA), CEA output neurons control the 
GABAergetic tone and form a spontaneous active neuron in lateral subdivisions. 
Aversive stimulus can reduce this inhibitory tone. CEA consists primarily of local-
ized GABA neurons and the inhibition of GABA occurs through GABAA α2 receptor. 
Therefore, for benzodiazepine-induced anxiolysis and anti-panic activity, CEA 
considered to be a significant target [28].
3.3 Epilepsy and GABAergic system
Epilepsy can be the consequence of disturbances in the homeostasis involving 
other neurotransmitters and neuromodulators, for example, glutamate, adenosine, 
norepinephrine, and acetylcholine. GABA receptor or transporter function altera-
tion can allow the occurrence of seizure in the presence of normal GABA levels. 
Some data indicates that low occipital lobe GABA concentration (remote from the 
seizure focus) is a risk factor for seizure recurrence. Low GABA levels predispose 
but may not be sufficient for seizures to become clinically effective [28, 29].
In case of adults, status epilepticus induces a complete re-organization of the 
networks, with cell death, axonal growth leading to an increased glutamatergic 
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drive. This, in turn, will decrease the threshold of seizure generation and thus con-
tribute to seizure generation. Somatostatin innervates the dendrites of the principal 
cells in the hippocampus and triggers a chemical imbalance between excitatory and 
inhibitory neurotransmitters which leads to a reduction of the inhibitory strength 
that is necessary but not sufficient to generate ongoing seizures. An additional 
important factor is the persistent increase of the intracellular chloride concentra-
tion that leads to a long-lasting shift in the depolarizing direction of the actions of 
GABA that will also contribute to seizure generation [30, 31].
4. Natural products and GABA
Due to the different binding sites present on GABA (A) receptor, various recep-
tor modulating compounds have been identified and depending on the mode of 
action, the affected binding site, and the compounds’ affinity. Radioligand binding 
assays have been confirmed the capacity of the ligand for the displacement of a mol-
ecule from its binding site. Various studies helped us understand the link between 
modulation of the receptor and associated effects, such as anxiolytic, sedative, and 
anticonvulsive properties (Figure 2; Table 1).
Radioligand binding assays are simple but influential tool for reviewing recep-
tors. They mainly analyze the interactions of hormones, neurotransmitters, growth 
factors, and related drugs with the receptors, studies of receptor interactions with 
second messenger systems, along with the characterization of regulatory changes 
in receptor number, subcellular distribution, and physiological function. So these 
assays are widely used in a numerous disciplines, including pharmacology, physiol-
ogy, biochemistry, immunology, and cell biology. The fundamentals of the radio-
ligand binding assay are fairly simple. The receptor of interest is incubated with 
an appropriate radioligand for a suitable period of time and then the radioactivity 
bound to the receptor is determined. There are three major types of experiments: 
Figure 2. 












Class of Compound Source Mechanism Active Componud In-Vivo/ In-Vitro Reference
Alkaloids






Electrophysiological studies, Radio 
ligand binding assay
[32, 33]
Leonurus japonicus GABA modulator Leonurine Radio ligand binding assay [34]
Piper nigrum GABA (A) receptor agonist Piperine
piperanine
Electrophysiological studies [35]
Annona purpurea GABA modulator Annomontine Elevated plus maze test [36]
Aconitum leucostomum non-competitive GABA(A) 
receptor antagonist




Sarcophytum auritum GABA agonist Ceramide Elevated plus maze test & Light dark 
test
[38]





Oenanthe crocata GABA (A) allosteric 
modulator
Falcarindiol Electrophysiological study [40]







Scutellaria baicalensis Allosterically blocks GABA-
mediated receptor
Oroxylin A Electrophysiological study, Radio 
ligand binding assay
[42]
Scutellaria baicalensis Acts at benzodiazepine site 
of GABAA receptor
Wogonin Radio ligand binding assay, Elevated 
plus maze test and hole board test
[43]
Scutellaria baicalensis Partial agonist of central 
benzodiazepine receptor





























Class of Compound Source Mechanism Active Componud In-Vivo/ In-Vitro Reference
Flavanes
Mentha aquatic Acts at benzodiazepine site 
of GABA receptor
(S)-naringenin Radio ligand binding assay [45]
Glycyrrhiza glabra Acts at benzodiazepine site 
of GABA receptor
Glabrol Radio ligand binding assay [46]
Isoflavanoids and 
chalcones
Adenocarpus cinncinatus GABA (A) receptor agonist 2′,4′,7-trihydroxy-8-(3-methylbut-
2-en-1-yl) isoflavone
Electrophysiology study [47]




Valeriana officinalis, Matricaria 
chamomilla, Lavandula officinalis










Electrophysiology study; Radio ligand 
binding assays
[50]
Thymus vulgaris GABA (A) receptor agonist Thymol Electrophysiology study [51]
Sesquiterpenes
Sideritis hyssopifolia GABA (A) receptor agonist α caryophyllene,
β caryophyllene
Electrophysiology study [52]














Class of Compound Source Mechanism Active Componud In-Vivo/ In-Vitro Reference
Atractylodes macrocephala GABA (A) receptor agonist Atractylenolide I
Atractylenolide II
Atractylenolide III
Electrophysiology study [47, 54]
Illicium anisatum non-competitive antagonist 
of GABAA receptor
Anisatin Electrophysiology study [55]
Diterpenes
Boswellia serrata GABA (A) receptor agonist Dehydroabietic acid Electrophysiology study [47]
Curcuma kwangsiensis GABA (A) receptor agonist Zerumin A
Coronarin D
Electrophysiology study [56]





Electrophysiology study [57, 58]
Triterpenes





A. racemosa GABA (A) receptor agonist 23-O-acetylshengmanol-3-O-β-D-
xylopyranoside
Electrophysiology study, Elevated Plus 
maze test and open field test
[59, 60]
Table 1. 
Natural compounds altering GABAergic transmission.
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saturation, kinetic, and inhibition. A saturation curve can be made by considering 
amount of receptor as constant and concentration of radioligand as variable. From 
this type of experiment the receptor density and the affinity of the receptor for the 
radioligand can be estimated. If the amount of receptor and radioligand is constant 
and the time is the variable, then kinetic data which are obtained from forward and 
reverse rate constants can be assessed. If the amount of a competing nonradioactive 
drug included in the incubation is the only variable, then the affinity (Ki) of that 
drug for the receptor identified by the radioligand can be estimated [61].
In Xenopus oocytes assay, xenopus oocytes are the immature egg cells of the South 
African clawed frog Xenopus laevis, these have striking appearance with two colors, 
the light colored vegetal pole and the dark animal pole, where the nucleus is found. 
TEVC recording (This method is a type of patch-clamp electrophysiology method 
to inject current into a cell with one electrode and recording the change in voltage 
with the other electrode) is used to measure membrane potential of the oocyte is 
clamped at a constant value. Two electrodes spear the oocytes in which one intracel-
lular microelectrode measures the membrane potential (voltage electrode) and the 
second one (intracellular microelectrode) controls the current. This is also called 
current electrode and uses as a feedback circuit to pass sufficient current to the oocyte 
for maintaining the voltage clamp. The current which is flowing through the current 
electrode can provide a measurement of the of chloride specific ion channels [62].
4.1 Alkaloids
Radioligand binding assay using [35S] TBPS and [3H] flunitrazepam analyzed 
the weak partial agonistic activity of Colchicine and (−) cornigerine along with six 
other colchicinoids from Colchicum brachyphyllum. These two molecules displayed 
25% of the action of 10 μM allopregnanolone, but the (−) activity of colchicines 
was none. (−) colchicines acted as a GABA competitive antagonis [32, 33]. GABA 
modulation is also recorded in proto alkaloid leonurine, belonging to an East Asian 
herb called Leonurus japonicus, indicated for anxiety, depression, nervousness, 
and insomnia. The molecule showed half-maximal inhibitory concentration (IC50) 
values of 15 μg/mL and 123 μg/mL, respectively in a radio ligand assay with [3H] 
gabazine and [3H] flumazenil [34].
Piperine and piperanine belonging to the class of piperidine-alkaloids were 
investigated in the immature egg cell of Xenopus laevis. The binding site of the 
molecule was confirmed to be a benzodiazepine binding site as Flumazenil  
(5 mg/kg) [35].
A β-carboline named annomontine also shows GABA dependant activity which 
was separated from the plant Annona purpurea [36]. In the EPM test, the compound 
increased the time spent in the open arms and the open arm entries at 10 and 
30 mg/kg, but not the total arm entries. These effects are controlled via the ben-
zodiazepine binding site as it was confirmed with antagonist Flumazenil at a dose 
of 3 mg/kg. Another alkaloid, a non-competitive GABA(A) receptor antagonist is 
diterpene alkaloid and this was separated from the plant Aconitum leucostomum hav-
ing an IC50 19.6 μM. Radioligand studies with the help of [
3H] muscimol produced 
an IC50 value of 7.06 μM and a Kd value of 6.31 nM. Specific binding site specific-
ity was shown by β-carbolines and picroacridine alkaloids as they bind to the 
benzodiazepine binding site Benzodiazepine binding sites can at least be excluded 
for piperidine alkaloids and protoberberine alkaloids. This holds for songorine in 
GABA/muscimol binding site as well [37].
Three colchicinoids displayed unspecific binding with weak action on both 
benzodiazepine and TBPS/bicuculline binding sites. Colchicine is the antagonist, 
but androbiphenyline and cornigerine are partial agonists. Protoalkaloid Leonurine 
Pharmacognosy - Medicinal Plants
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shows binding to various sites, with decreased affinities to, GABA/muscimol and 
the benzodiazepine binding site. Protoberberine type 2 alkaloids were able to 
modulate GABA(A) receptors, but unsaturated type 1 alkaloids displayed no effects.
4.2 Alkanes
The odor substance, 1-octen-3-ol is part of the GABAA sensory receptor modi-
fication research and has a stimulation rate of 295 ± 50 percent at a particular 
concentration of 300 μM and 1 μM GABA [52]. Ceramide (N-[(2S,3R,4E,6E)-1,3-
dihydroxyhenicose-4,6-dien-2-yl] tridecanamide) separated from the Red Sea soft 
coral Sarcophytum auritum. This works as GABA agonist and produce anxiolytic 
effect in animal models evaluated by EPM test in which the animal spent more time 
in open arms and time spent in light in light/dark test whereas all its action can be 
altered by the action of bicuculline (GABA antagonist) [38, 52].
Two polyacetylenes extracted from Oenanthe fistulosa, Oenanthotoxine and 
dihydroenanthotoxine, provided major inhibitory activity on GABA receptors 
with IC50 values of 0.835 μM and 1.29 μM respectively on GABA (A) receptors 
The potential explanation for the indications which include water drop worm 
intoxication (Oenanthe crocata) and facial muscle contractions which is due to the 
inhibition of GABAergic reactions. The substance that allosterically regulate GABA-
binding, non-competitively inhibits ion channel and also eradicates the desensitiza-
tion of the receptor was constituted by modes of action of oenanthotoxin [39].
At a very low concentration the component falcarindiol obtained from Oenanthe 
crocata effectively regulates GABAergic currents. This component at low concentra-
tion (1 μM for falcarindiol and 0.1 μM for falcarinol) promotes the ion currents 
caused by GABA, on the other hand at higher concentration it inhibits the action of 
GABA. Moreover, the sedative but not convulsive result in animals is triggered by the 
low-dose effect, whereas the large doses in insect herbivores act as insecticides [40].
The three polyacetylenes MS-1, MS-2, and MS-4 were obtained from Cussonia 
zimmermannii with recorded GABA(A) modifying activity [41].
However, the potency and/or affinity were demonstrated in the small micro 
molar range, but that varies significantly in terms of toxicity. Two structural char-
acteristics (groups of allyl and terminal hydroxyl) that are present in five (most) 
poisonous natural products produced toxicity. It suggests that the terminal hydroxyl 
class is vital for the toxicity. Further, both the oenanthotoxins and dihydrooenan-
thotoxins require the allyl hydroxyl group but are highly toxic. On the other hand 
falcarinol and falcarindiol, which have an allylic class but not the final hydroxy 
group, showed decreased toxicity. None of the two “toxic characteristics” are pres-
ent in the last three polyacetylenes group and are also not documented to display 
inhibitory behavior consistent with this theory. It would be necessary to investigate 
whether hydrolyzation has led to GABA (A) receptor antagonism because MS-4 has 
a terminal acetyloxy-group [38, 52].
4.3 Flavones
The substance Oroxylin A, allosterically to block GABA-mediated receptor by its 
action on chloride currents, and thus it describes the results of a previous in vivo study 
in which the substance exhibited antagonistic diazepam-induced effects [42, 43].
Wogonin was considered for the induction of GABA-induced chloride currents 
by using electrophysiological methods where it shown a stimulation of 57% at a 
concentration of 30 μM in the presence of 1 μM GABA where at 3 μM half maximal 
stimulation was noticed. It was also tested pharmacologically at a dose of 7.5, 15 and 
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30 mg/kg by using Elevated plus maze and hole board test. The wogonin showed 
anxiolytic effects. These data recommend that wogonin yielded anxiolytic by posi-
tive allosteric modulation of the GABAA receptor complex through benzodiazepine 
site interaction [43].
The chrysin is from Scutellaria baicalensis class which was separated from 
Passiflora caerulea [44, 63]. Chrysin was testified as partial agonist of central 
benzodiazepine receptors which reduced anxiety and does not induced sedative and 
muscle relaxation. The pharmacological effect of chrysin was observed in mice at 
1 mg/kg in Elevated plus maze test. The anxiolytic effect was observed by increas-
ing the number of entries and time spent in the open arm. The horizontal wire test 
showed a decreased percentage of animals grasping the horizontal wire, while in the 
hole board test an increase in time spent head-dipping at 3 mg/kg was observed, but 
no sedative effects at doses of 3 and 6 mg/kg [44].
Flavone compounds like wogoninnn and chrysin shows diazepam like anxiolytic 
effect whereas Oroxylin A antagonizing the effects provoked by diazepam.
4.4 Flavanes
(S) naringenin was isolated from the ethanol extract of leaves Mentha aquatica 
and evaluated against [3H] flumazenil which exhibits an IC50 value of 26 mM. This 
compound can effectively modulate GABA function [45].
Glabrol, is the prenylated flavanone its three Diels-Alder type derivatives, 
sanggenon C, D, and G and were obtained from the root extract of Morusalba. All 
three molecules, with EC50 values in the range from 13.4 to 16.7 μM, increased 
chloride-induced GABA by over 700 percent (100 μM) [46].
In particular, two 8-lavandulyl-flavanones produced GABA-induced chloride 
impulses to potentiate by about 600 percent compared to the third 8-lavandulyl-
flavanonol which is substantially less active.
The compounds like (S) naringenin, glabrol and 8-lavandulyl-flavanones acts 
at benzodiazepine site of GABA receptor which was analyzed using radio ligand 
binding assay.
4.5 Isoflavanoids and chalcones
Adenocarpus cinncinatus considered as the source of 2′, 4′, 7-trihydroxy-
8-(3-methylbut-2-en-1-yl) isoflavone. Its stimulatory effect exhibits a uplift of 
GABA-induced chloride currents [64]. At a concentration of 30 nM, the substance 
increased GABA-induced chloride currents by 135 percent with a maximum poten-
tiation of 581 percent at a level of 100 μM.
Isoliquiritigenin increased GABA-induced currents by of 151% at a dose of 10 M 
with a patch-clamp method on dorsal raphe neurons [48].
The Sophora flavescens lavandulyl chalcone is Kuraridine, which potentiates 
GABA-induced chloride currents by 719.7 percent at a dose of 10 M with a maximal 
activation rate of 891.5 percent [56].
The findings for isoflavonoids and chalcones are consistent with the results of 
the last two sections: isoflavone genistein blocks chloride currents in the same way 
as its flavone equivalents apigenin. The binding of [3H] flunitrazepam inhibits 
chalcone isoliquiritigenin, furthermore the prenylated types show a marked ability 
of more than 500 percent (95.97) to around 900 percent.
In these compounds the substitution of one hydroxy and one methoxy group in 
both aromatic rings shows better potency. Overall, all of these compounds shown 
GABA (A) receptor agonist type action.




(+) borneol, (−) borneol, (−) bornyl acetate, is borneol, and camphor acting 
on GABA(A) receptors which were stated in oocytes of Xenopus laevis. With the 
increased stimulation reported for (+)-borneol and (−)-borneol, all other sub-
stances resulted in a marked maximum potentiation of GABA-induced chloride cur-
rents. EC50 values were, however, in the large micromolar range with the smallest 
score reported for bornyl acetate (111.2 μM) [49, 65].
In a radioligand binding assay measured on α and β thujone against [3H] EBOB, 
where the substances displayed IC50 values of 13 and 37 μM. The β-thujone was 
identified as a non-competitive antagonist with an IC50 value of 21 μM in addi-
tional electrophysiological studies. Studies have confirmed these molecules acts 
by allosteric decrease of GABA-induced chloride currents. α-thujone has been 
reported in a survey on GABAergic miniature inhibitory currents to decrease 
their frequency and amplitude and to moderately influence their kinetics. The 
study concluded that alpha-thujone had gating receptor activity as this substance 
decreased the amplitude of current reactions to exogenous GABA and influenced 
their initiation, desensitization, and neutralization [50]. Epoxy-carvone was stud-
ied using MES, PTZ, and picrotoxin-induced seizure models for its anticonvulsant 
properties [66].
In Xenopus oocytes, thymol an aromatic monoterpene is known from a variety of 
Thymus species, was examined on α1 β2 γ3 where chloride-induced GABA-currents 
increased by 416% at a concentration of 100 μM [51].
Isopulegol has been tested in-vivo for its anxiolytic ability. In the hole board 
test and Elevated plus maze [EPM] test at a concentration of 25 and 50 mg/kg, the 
isopulegol has been shown to raise the number of head dips in the hole board test 
which specifies anxiolytic effect in which the number of open arm entries along 
with the time spent in the arm was also increased in EPM test. In the EPM test of 
isopulegol results reduced the animal’s aversion to the open arms as well as pro-
moted the exploration which specifies anxiolytic effect [67].
In an anxiolytic-like behavioral study, the (+)-limonene epoxide at various 
doses of 25, 50, and 75 mg/kg showed an improvement in open arms inputs and 
time spent in open arms in the EPM test and decrease in the number of crossing, 
grooming, and rearing is found in the open field test, further implying the sedative 
effects of the drug [55]. The anxiolytic effect was reported by a follow-up study in 
which the compound demonstrated a decrease in the number of buried marbles 
in the buried marble test at a dose of 25, 50, and 75 mg/kg [68]. In several studies, 
Carvacryl acetate was also tested for anxiolytic and sedative effects. The EPM test 
shows that the compound increased the number of open arm entries at a dose of 
100 mg/kg and the time spent in the open arm at doses from 25 to 100 mg/kg. In 
case of the light/dark test it increased the number and time spent in the light area at 
doses from 25 to 100 mg/kg. In the buried marbles test reduction of buried marbles 
number was observed at doses from 25 to 100 mg/kg, but no co-ordination impair-
ment in the Rotarod test and no decrease in locomotor activity is observed in the 
open field test were measured at the same doses [69].
A few monoterpenes have been studied for their GABA receptor modulation 
action and the highest potential of chloride channel opening was observed for 
bicyclic alocohols, like (+) and (−)-borneol whereas isoborneol showed distinct 
potentiation. Oxidation of the hydroxy-group or the presence of an exocyclic 
methylene group causes decrease in the activity. The only monocyclic monoterpenes 
positive receptor modulation was observed by thymol.
15
Natural Products Altering GABAergic Transmission
DOI: http://dx.doi.org/10.5772/intechopen.99500
4.6.2 Sesquiterpenes
Two monoterpenoid moieties namely α caryophyllene and β caryophyllene 
belonging to Sideritis sp. that displayed medium modulation of GABA-mediated 
chloride channels (117 and 115%, respectively).
Curdione and curcumol were extracted from the oil of Curcumaerhizoma and 
were tested on GABAA receptors expressed. The molecules increased GABA-
mediated chloride channel activity with 133 and 175.7%, respectively at a concen-
tration of 50 μM. The EC50 value of Curcumol was found to be 34.4 μM and the 
highest activity of 251% was found at 300 μM [53].
The highest induction of GABA-mediated chloride channel of around 400% was 
found in (+) cuparenol and (+)-dihydrocuparenic acid.
At 300 μM, when Atractylenoids I, II and III from Atractylodesmacrocephala was 
tested on GABA (A) receptors highest stimulation of 96 to 166% was observed with 
an EC50 value of 12, 70 and 99 μM, respectively [54, 70].
Anisatin is oxygenated sesquiterpene lactone separated from Illicium anisatum is 
a potent noncompetitive antagonist of GABAA receptor that has an activity similar 
to picrotoxin [71]. Studies demonstrated that anisatin at 1 μM decreased chloride 
currents created by 30 μM GABA to 41.7%. The IC50 value was measured with 
1.10 μM along with an IC50 value of 0.42 μM for picrotoxinin, which is the active 
compound of picrotoxin was obtained. An indication that anisatin binds to the pic-
rostatin site of the receptor was shown in a radioligand binding assay with an IC50 
value of 0.43 μM against [3H] EBOB. One very potent sesquiterpene is xenovulene 
A, which was separated from the fungus Acremonium striatum (now classified as 
Sarocladium striatum) [72].
As a result of the structural differences of the sesquiterpenes only restricted 
conclusions on their structure–activity relationship can be drawn. Reduction of the 
acidic function to an alcoholic function does not change the activity whereas the 
change of the isopropenyl-function of compound to a plane isopropanyl-moiety 
leads to a significant loss of activity.
4.6.3 Diterpenes
In this Section 14 diterpenes which are having the actions on GABA are dis-
cussed. Miltirone, a Salvia miltiorrhiza tanshinone, was assessed against [3H] 
flunitrazepam with an IC50 value of 0.3 M in a radioligand-binding analysis [73].
Dehydroabietic acid has been segregated and examined in Xenopus laevisocytes 
from Boswellia thurifera, now known as Boswellia serrata [47]. GABA-induced chlo-
ride currents were enhanced by the substance by 397.5 percent at 100 μM and dis-
played an EC50 value of 8.7 μM. Isopimaric and sandaropimaric acid were extracted 
and examined from Biota Orientalis, currently known as Platycladusorientalis, in 
the Xenopus oocyte assay [74]. The substances showed a maximum stimulation 
effect of 425.2 and 855.7 percent of GABA-induced chloride currents at 500 μM and 
EC50 values of 141.6 and 33.2 μM, respectively.
Two diterpenes of phyllocladane namely 17-dihydroxyphyllocladane-3-one and 
16,17,18-trihydroxyphyllocladane-3-one types were obtained from Aloysia virgata 
and assessed for GABA(A) affinity to [3H] flumazenil with inhibitory constant [Ki] 
of 111 and 56 μM. Both compounds were studied in vivo, with compound, 17-dihy-
droxyphyllocladane-3-one which exhibits increased locomotor activity at a dose of 
1 mg/kg in the locomotor activity test and increased rearing at 0.3 and 1 mg/kg in 
the hole board test. Compound 16,17,18-trihydroxyphyllocladane-3-one increased 
the number of head dips at 0.3 and 3 mg/kg, the number of rears at a dose of 1 mg/
kg and the time spent head-dipping at a dose of 3 mg/kg. The compound at a dose 
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of 1 mg/kg increased the number of open arm entries in the EPM test and the time 
spent in the light area as well as the number of transitions in the light/dark test [75].
Two diterpenes of type labdane, cerumin A and coronarin D, were obtained 
from Curcuma kwangsiensis [57]. In the Xenopus oocyte assay, substances at a 
300 M concentration stimulated GABA-induced chloride currents by 309.4 and 
211.0 percent, with EC50 values of 24.9 and 35.7 M. Ginkgolides A B and C which 
are diterpene trilactones of Ginkgo biloba, are moderately active GABAA receptor 
antagonists with Ki values of 14.5, 12.7 and 16.3 M in Xenopus laevis oocytes [58].
Some results suggest that compounds like 7-methoxyrosmanol and galdosol 
increases 10-fold receptor affinity by an oxo-group at 7nth position instead of 
methoxy group. On the other hand, for compounds isopimaric acid and sanda-
ropimaric acid, the change from the 7th to the 8th position of the double bond and 
thus to the C-ring of the substance doubles the maximum stimulatory effects and 
significantly decreases the EC50 value There are no clear variations in the inhibitory 
action of bilobalide and ginkgolide A-C in their IC50 values or in their ability to 
inhibit chloride current induced by GABA. Therefore, all these diterpenes works as 
GABA receptor agonists which help in chloride current flow.
4.6.4 Triterpenes
Asiatic acid was separated from Centella Asiatica and its anxiolytic effects were 
analyzed in the EPM test. The compound displayed no action on the open arm time 
but reduced the motile time and the highest speed at 30 mg/kg. These actions were 
blocked by flumazenil [76].
Ginsenoside C, is a glycoside isolated from Panax ginseng was tested on 
GABA(A) receptors expressed in xenopus laevis oocytes which were found to 
potentiate GABA-induced chloride currents with an EC50 value of 53.2 μM [77].
Four cycloartane glycosides actein, cimigenol-3-O-β-D-xylopyranoside 
25-O-acetylcimigenol-3-O-α-L-arabinopyranoside, 23-O-acetylshengmanol-3-
O-β D-xylopyranoside were extracted from Actaea racemosa root systems (black 
cohosh) and assessed in Xenopus laevis oocytes for their capacity for GABA-induced 
chloride currents [74]. Substances like actein, cimigenol-3-O-β-D-xylopyranoside 
and 25-O-acetylcimigenol-3-O-α-L-arabinopyranoside which are isolated constitu-
ents from rhizomes of Actaea rasemosa exhibited potentiation of GABA-induced 
chloride currents in the range of 256 to 378 percent at a concentration of 300 M, 
while 23-O-acetylshengmanol-3-O-D-xylopyranosides reported stimulation of 
1947 percent and were also shown to generate small chloride currents due to lack of 
GABA. The EC50 values for the four glycosides were estimated from 26 to 36 μM. 
The pentose moiety cleavage led to a substantial decline in anxiety-related behavior 
(particularly for substance 23-O-acetylshengmanol-3-O-D-xylopyranosides. This 
compound was used in several in-vivo studies for the examination of its anxiolytic 
and sedative properties. It increased the number of open entries at 0.6 mg/kg in 
the EPM test whereas reduced stress-induced hyperthermia at doses of 0.2, 0.6, 2 
and 6 mg/kg. In the open field test, this compound reduced the distance traveled at 
doses of 6, 20 and 60 mg/kg and also increased the time spent in the centre at a dose 
of 60 mg/kg, while the number of entries into the centre was reduced [60].
The discussion of the structure–activity of triterpenes is not influenced by the 
lack of comparable structures (scaffolds) compared to the last two subsections, 
but by the variety of test systems used for their analysis. However, it is possible to 
compare at least some of the known triterpenes from ginseng and black cohosh. 
Electrophysiological data showed lower EC50 levels for the three ginseng triter-
penes ginsenoside C. Unfortunately, the maximum chloride current stimulation 
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values were only observed for the two aglycones and were recorded to be 54.1 and 
23.3 percent, respectively (at a concentration of 100 M). It can be concluded that 
the receptor modulation of the glycoside would be of significant concern after 
examining substance 23-O-acetylshengmanol-3-O-D-xylopyranosides, where the 
xylose moiety cleavage changed the potentiation of GABA-induced chloride cur-
rents from 1692 percent to 64 percent (100 M) and thus into the range of ginseng 
aglycon. Both compounds 23-O-acetylshengmanol-3-O-D-xylopyranosides and 
ginsenoside C disclose a four-ring structure with a side chain linked to ring D 
when contrasting their scaffolds. The prenylate and oxyprenylate side chains have 
enhanced activity, which is reminiscent of the structure-action-relationship of 
coumarins. The ginsenoside side-chain will stand for the prenyl moiety in the case 
of the triterpenes under consideration and that of substance23-O-acetylsheng-
manol-3-O-D-xylopyranosides for the more active epoxylated form. However, 
this molecule has additional characteristics that may contribute to its pronounced 
effect, such as keto-function at position 16 or acetyloxy-group at C-23, which both 
differentiate the compound from the other slightly less active cycloartanoids [59].
The neurosteroid binding site would be most obvious and consistent with the 
fact that neurosteroids are the most effective natural GABAA receptor modulators 
and, in the absence of GABA, are also capable of evoking chloride currents [78]. 
However, the hydroxy group at position 3 and the keto group at position 17 or 20 
are considered to be important for neurosteroid binding activity. As far as the 
structure of compound is concerned, the keto group may well lead to the binding 
of the receptor in position 16 instead of position 17, but the fact that the role of the 
compound almost vanishes with the xylose moiety does not support this theory 
unless the binding of the neurosteroid site can be improved by the residue of sugar 
instead of the hydroxy group in position 3. Barbiturates, on the other hand, are also 
known to activate GABA(A) receptors directly at higher concentrations and the site 
of barbiturate binding is thought to be similar to that of neurosteroids [79].
5. Conclusion
Natural products with GABA receptors activity were identified in the literatures 
and discussed in this chapter. Depending on the number of related compounds and 
test systems used, it was possible to draw in the vicinity of conclusions regarding 
their structure–activity relationships. As most of the studies examined flavones, 
and these studies mainly applied radio ligand binding assays, substitution patterns 
responsible for increased receptor affinity could be associated with one flavone 
even with diazepam-like Ki values. As far as receptor regulation is concerned, fla-
vones are either non-competitive antagonists or partial agonists. However, certain 
compounds also exhibited anxiolytic or anticonvulsant effects. Other phenolic 
compounds addressed in this study were, for example, coumarins, where prenyl-
ated compounds demonstrated higher stimulation of the receptor. The association 
of phenyl residues and pronounced receptor modulation has also been observed 
for flavanes, isoflavonoids, and chalcones and may be of interest to the production 
of GABA(A) receptor modulators. Besides, the structural features required for the 
positive or negative regulation of the polyacetylene and monoterpene receptors as 
well as the effect of deglycosylation on certain triterpenes have been highlighted. 
Very few studies have been found on the subtype-specificity of natural products. 
One example is the enhanced modulation of isopimar and sandaropimaric acid 
receptors after the exchange of α1-subunit for α2 or α3-subunits. Neolignane 
honokiol must also be stated in this sense, although the effect was more dependent 
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on the GABA(A) receptor subunits. Data obtained from recorded in vivo studies 
may be helpful in this regard, as many compounds have been known to exhibit 
anxiolytic effects without exhibiting sedative or muscle relaxant properties.
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